Pharmaceutical industry in Switzerland
The pharmaceutical industry in Switzerland directly and indirectly employs about 135,000 people. It contributes to 5.7% of the gross domestic product of Switzerland and contributes to 30% of the exportations.
Switzerland is home to many pharmaceutical companies, including very large groups such as Novartis and Hoffmann-La Roche. In 2013, 41 life science companies have their international headquarters (and 29 more their regional headquarters) in Switzerland.
- 1896: foundation of Hoffmann-La Roche.
- 1933: foundation of Interpharma.
- 1950s: Cilag merged with Janssen Pharmaceutica, into Janssen-Cilag.
- 1996: Ciba-Geigy merged with Sandoz, with the pharmaceutical and agrochemical divisions of both staying together to form Novartis. Other Ciba-Geigy and Sandoz businesses were sold off, or, like Ciba Specialty Chemicals, were spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz.
- 1990: Hoffmann-La Roche owns a majority of Genentech. It will be completely integrated in 2009.
- 2000: Novartis divested its agrochemical and genetically modified crops business with the spinout of Syngenta, in partnership with AstraZeneca which also divested its agrochemical business.
Basel is home to Novartis (Sandoz), Hoffmann-La Roche, Basilea Pharmaceutica, Actelion and Straumann. In 2013, Novartis and Hoffmann-La Roche are respectively the second and third world biggest pharmaceutical companies (preceded by Pfizer and followed by Merck & Co. and Sanofi).
In addition to pharmaceutical companies (65 companies), Switzerland many companies in the fields of biotechnology (338 companies) or medical devices and technology (341 companies). According to KPMG, there are 120 life science companies in Basel, 132 in Zürich and 92 in the Lemanic region.
In addition to that, there are 500 laboratories from universities and university hospitals (in the Lemanic region).
Notes and references
- Stephan Vaterlaus, Stephan Suter and Barbara Fischer, "The Importance of the Pharmaceutical Industry for Switzerland", A study undertaken on behalf of Interpharma, September 2011.
- Site Selection for Life Sciences Companies, European Life Sciences Cluster 2013 Report, KPMG (page visited on 4 November 2013).
- (French) Willy Boder, "La Suisse compétitive dans les sciences de la vie", Le Temps, Tuesday 5 November 2013, p. 15.
- (French) Willy Boder, "Le grand chambardement de la pharma", Le Temps, Monday 7 July 2014, page 17.
- (French) Health Valley, L'Hebdo, 2010.
- (French) Karl Lüönd, Principe actif: la connaissance. Passé et présent de l'industrie pharmaceutique suisse, Interpharma and éditions Neue Zürcher Zeitung, 2008.
- Economy of Switzerland, List of companies of Switzerland
- Science and technology in Switzerland
- European Federation of Pharmaceutical Industries and Associations, List of pharmaceutical companies
- List of largest European manufacturing companies by revenue, List of largest manufacturing companies by revenue
- Life Sciences Switzerland
- Health Valley
|Wikimedia Commons has media related to Pharmaceutical industry in Switzerland.|